A
ALNY
Alnylam Pharmaceuticals, Inc. Common Stock
$224.47
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Alnylam Pharmaceuticals, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
$5.88
P/E
37.6
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $1.78
Oct 29
Posts
No posts about ALNY yet.
About Alnylam Pharmaceuticals, Inc. Common Stock
Alnylam Pharmaceuticals is a biotechnology company that develops medicines based on RNA interference, a method that switches off specific genes that cause disease. It sells approved drugs for rare genetic conditions, including nerve and heart diseases, and earns money from those product sales plus royalties and partnership payments.